- Home
- LPTH vs LXEO Comparison
LPTH vs LXEO Comparison
Compare LPTH & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LPTH | LXEO |
|---|---|---|
| Founded | 1985 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.1M | 486.1M |
| IPO Year | 2011 | 2023 |
Fundamental Metrics
Financial Performance| Metric | LPTH | LXEO |
|---|---|---|
| Price | $11.38 | $5.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $13.33 | ★ $18.60 |
| AVG Volume (30 Days) | ★ 1.9M | 700.3K |
| Earning Date | 02-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.08 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $37,202,630.00 | $654,000.00 |
| Revenue This Year | $81.01 | N/A |
| Revenue Next Year | $25.69 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.26 | N/A |
| 52 Week Low | $1.61 | $1.45 |
| 52 Week High | $15.24 | $10.99 |
Technical Indicators
Market Signals| Indicator | LPTH | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 29.40 |
| Support Level | $11.03 | $4.67 |
| Resistance Level | $13.76 | $7.77 |
| Average True Range (ATR) | 0.83 | 0.49 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 52.68 | 4.37 |
Price Performance
Historical ComparisonAbout LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.